课题基金 / 基金详情

FDA-Drug Residue Cooperative Agreement Program (U18)

FDA-Drug Residue Cooperative Agreement Program (U18)
FDA-药物残留合作协议计划(U18)
批准号:
9770853
负责人:
William Gamble
金额:
$15.0万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-01 至 2021-06-30

项目摘要

项目成果

William Gamble的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Iowa Department of Agriculture & Land Stewardship (IDALS) Project Summary/Abstract Drug Residue Prevention Program (U18) Given the large impact of Iowa's feed manufacturing industry, providing information through education about the prevention of drug residue based on the scientific principles of feed/food safety is paramount to protecting Iowans and consumers throughout the nation and world. Our ability to follow up on residue violations and work side by side with the producer to find a solution is value added to the supply chain. Furthermore, the President has provided a significant level of focus on food safety nationally as has Congress with the passage of the Food Safety Modernization Act (FSMA). Similarly, within Iowa we have found an added interest in food safety. Speaking to groups to provide information through education is a large part of what our Bureau has identified to be successful with the FDA Drug Residue Cooperative Agreement Program. Initially the Bureau will restructure duties of existing staff to allow us time to evaluate if a new staff person is needed to assist in this area. We will continue to update and educate our inspectors about the prevention of drug resides. We will develop drug residue prevention material that will include a survey which our inspectors will hand out at all of our 500+ inspections throughout the year. Our inspectors will be properly trained so they can answer any questions that they may receive. We will enhance, and make available, the existing pamphlets that are already being used by the Animal Industry Bureau as well as create our own. We will make sure the information can be relayed to the public in a manner than can be understood. We will make available the drug residue materials at select fairs as well as being involved with mailings. We will record the event/webinar of a training seminar and post it onto a designated Drug Residue Prevention webpage so it can be available to anyone at any time. The recorded seminar along with the informational pamphlets will be posted on our website so they will be available to everyone. The material will continue to be available after the end of the agreement. The objective of this agreement is intended to ensure that IDALS enhances our drug residue prevention program to protect consumer exposure to drug residues in the edible products of food animals. This will be achieved by educating laypersons and practitioners of the risks of drug residues and providing them methods of prevention. Following up on past violations will also enable the future producers/manufacturers to gain knowledge that will assist in the prevention of the violation from occurring again. These steps IDALS will be taking will significantly enhance the quality of food sold in and from Iowa.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IA ERPS Cooperative Agreement
IA ERPS Cooperative Agreement
IDALS/FDA AFRPS Maintenance with PC Regulatory Activities
IDALS/FDA AFRPS Maintenance with PC Regulatory Activities
国内基金
海外基金
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    杨胜彩
  • 依托单位:
Drug-ADR-Pathway复合网络构建及ADR分子机制研究
  • 批准号:
    61372188
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    陈秀杰
  • 依托单位:
Drug-pHLA对接指纹图谱库的构建及HLA介导SADR的预测方法研究
  • 批准号:
    61073135
  • 项目类别:
    面上项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2010
  • 负责人:
    梅虎
  • 依托单位:
新型药物传输系统drug-LDHs 复合纳米粒子的可控制备及其微结构对缓控释性能的调控
  • 批准号:
    20776012
  • 项目类别:
    面上项目
  • 资助金额:
    31.0万元
  • 批准年份:
    2007
  • 负责人:
    张慧
  • 依托单位: